Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Intellipharmaceutics International Inc
IPCIQ
Healthcare
Biotechnology
Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this...
technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IPCIQ)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
Next
(8)
•••
TheAlligator
X
View Profile
View Bullboard History
Comment by
TheAlligator
on Jan 16, 2020 9:42am
RE:Anyone selling this morning...
The market has proven you wrong. As much as it might hurt mentally, its better to take the loss and move on even if you get 20 cents on the dollar. You don't know if this would slowly creep up to
...more
(16)
•••
pecuniam
X
View Profile
View Bullboard History
Comment by
pecuniam
on Jan 16, 2020 9:41am
RE:Anyone selling this morning...
Thanks for the .19 cent shares. Ridiculous!
(16)
•••
pecuniam
X
View Profile
View Bullboard History
Post by
pecuniam
on Jan 16, 2020 9:35am
Anyone selling this morning...
is a complete fool.
(2)
•••
Nogah3
X
View Profile
View Bullboard History
Comment by
Nogah3
on Jan 16, 2020 9:24am
RE:RE:Pipeline
Respectfully Kamooz, I think you missed the point. If oxycodone is going to be approved then that would open a $1.3 Bil market. Well IPCI just recently signed three of its FDA approved drugs that are
...more
(16)
•••
pecuniam
X
View Profile
View Bullboard History
Post by
pecuniam
on Jan 16, 2020 9:05am
Bid .12 Ask .12 Seriously!
What a joke. Holding my shares now.
(4)
•••
Kamooz
X
View Profile
View Bullboard History
Comment by
Kamooz
on Jan 16, 2020 8:31am
RE:Pipeline
Nogah3, i have to disagree with you on one thing; when you said "revenue is about to get a boost in Q4, even without Oxycodone". I believe you are wrong, I don't know if it's
...more
(13)
•••
Guepard
X
View Profile
View Bullboard History
Comment by
Guepard
on Jan 16, 2020 7:41am
RE:Pipeline
You must surely know what you write, for the moment, it doesn't look good, but I keep my shares. Thank you for your details and do not hesitate to write again. Thank you
(2)
•••
Nogah3
X
View Profile
View Bullboard History
Post by
Nogah3
on Jan 16, 2020 1:36am
Pipeline
Hi all, Lots of chatter about what typically goes on with companies like this. To provide some clarity, I think we need to look at the real reason that drove the company's resurgence over the
...more
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 15, 2020 11:49pm
RE:RE:RE:trading halt
only because the AdCom rejected it doesn't mean FDA will do the same, there is a big pressure in the US to do something about the opioid crisis and IPCI has the best solution for that so far. Also
...more
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 15, 2020 11:41pm
RE:RE:trading halt
the info about AdCom rejecting the drug comes mainly from the Stocktwits, nothing official yet but those guys know everything
(1)
•••
OK_trade
X
View Profile
View Bullboard History
Comment by
OK_trade
on Jan 15, 2020 11:22pm
RE:trading halt
Could you explain how did you obtain this info? Thanks.
(16)
•••
pecuniam
X
View Profile
View Bullboard History
Post by
pecuniam
on Jan 15, 2020 10:50pm
Aww! These never go my way.
Now I'll be gun shy again and hesitate on the next one then it will triple over night and I'll be on the sidelines. Fate...I guess.
(68)
•••
bigkagan
X
View Profile
View Bullboard History
Comment by
bigkagan
on Jan 15, 2020 10:10pm
RE:trading halt
I could have sold shares yesterday and made a nice profit but I decided to go all the way and wait for the FDA decision, it was a pure Vegas-like gamble which didn't pay off but if I sold it to
...more
(0)
•••
attempter
X
View Profile
View Bullboard History
Post by
attempter
on Jan 15, 2020 9:13pm
trading halt
The Oxycontin drug applicatin was denied by the FDA this afternoon.
(14)
•••
crossfit11
X
View Profile
View Bullboard History
Comment by
crossfit11
on Jan 15, 2020 8:08pm
RE:RE:Halted
The halt came out at 1:30 this afternoon stating the reason as " pending news". The company has not issued a news release yet so we can only speculate at this time but considering they had a
...more
Prev
1
2
3
4
5
6
7
8
9
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
LEARN about a Biotech Rising to New Heights and Transforming Regenerative Medicine